158 results on '"Liauw, S."'
Search Results
2. FORMULA-509: A Multicenter Randomized Trial of Post-Operative Salvage Radiotherapy (SRT) and 6 Months of GnRH Agonist with Either Bicalutamide or Abiraterone Acetate/Prednisone (AAP) and Apalutamide (Apa) Post-Radical Prostatectomy (RP)
3. Patterns of Recurrence Following Radiation and ADT for Pathologic Lymph Node Positive Prostate Cancer: A Multi-Institutional Study
4. Contemporary management of men with high-risk localized prostate cancer in the United States
5. Phase II Randomized Study of Salvage Radiation Therapy (SRT) plus Enzalutamide or Blinded Placebo for High-Risk PSA-Recurrent Prostate Cancer after Radical Prostatectomy: The SALV-ENZA Trial
6. Incidence and Severity of Hematuria After Post-Prostatectomy Radiotherapy in a Cohort With Long-Term Follow-up
7. Intra-Operative Radiation Therapy and Surgical Excision for Locally Recurrent Gastrointestinal Cancers: Initial Results of a Single-Institution Registry
8. Grade migration in prostate cancer: an analysis using the Surveillance, Epidemiology, and End Results registry
9. Erratum: Contemporary management of men with high-risk localized prostate cancer in the United States
10. Medication Allergies are Associated with Late Toxicity in Men Treated with Radiation Therapy for Prostate Cancer
11. Phase I Study of Stereotactic Body Radiotherapy followed by Ipilimumab with Nivolumab vs. Nivolumab alone in Unresectable Hepatocellular Carcinoma
12. A Prospective Trial Of Oral-Only Hormonal Therapy With Radiation For Unfavorable Prostate Cancer In Older Men Or With Comorbidity And An Associated Transcriptomic Analysis
13. Acute/Chronic respiratory failure
14. PI-RADS Score Is Associated with Clinical Outcome in Men Treated with Radiation Therapy for Prostate Cancer
15. Implementation of a Commercially Available Platform to Monitor Intrafraction Motion of the Prostate: Lessons Learned from a Feasibility Study in Men Treated with Hypofractionated External Beam Radiation Therapy
16. Largest Axial Dimension of Tumor on T2W Endorectal MRI is Associated with Biochemical Outcome in Men Treated with External Beam Radiation Therapy for Prostate Cancer
17. Improved Long-Term Outcomes after Radiation Therapy for Prostate Cancer for Men on Anticoagulation: Low Platelet Count as a Contributing Factor in Disease Recurrence
18. A Prospective Cohort Study of Patient Reported Outcomes and Late Toxicity in Patients Receiving Post-Prostatectomy Intensity Modulated Radiation Therapy (IMRT)
19. Application of a Prognostic Stratification System for High-Risk Prostate Cancer to Patients Treated with Radiation Therapy: Implications for Treatment Optimization
20. A Phase I/II Trial of Stereotactic Body Radiation Therapy for Unresectable Pancreatic Cancer Using Ablative (BED100) Doses
21. Optimizing the Role of Surgery and Radiation Therapy in Urethral Cancer Based on Histology and Disease Extent
22. Impact of Radiation Oncology Training Program Location on Region of Job Securement across Two Time Periods
23. BASELINE CHARACTERISTICS AND CLINICAL OUTCOMES OF HOMELESS ADULTS PRESENTING TO AN INNER CITY STEMI NETWORK HOSPITAL
24. Long-Term Outcomes and HPV Characteristics for an Institutional Cohort of Patients With Anal Cancer Receiving Concurrent Chemotherapy and Intensity-Modulated Radiation Therapy
25. Multi-institutional Outcomes of Postprostatectomy Adjuvant Versus Early Salvage Radiation Therapy in Prostate Cancer Patients With Adverse Pathologic Features
26. Intraprostatic Disease Burden and Extracapsular Extension by MRI May Identify Men With Intermediate-Risk Prostate Cancer Who Benefit from Combined Hormonal Therapy and Radiation
27. Prostate Cancer–Specific Mortality and Survival Outcomes for Salvage Radiation Therapy After Radical Prostatectomy
28. Benefit of Elective Nodal Irradiation and Androgen Deprivation Therapy with Postprostatectomy Salvage Radiation Therapy for Prostate Cancer
29. Using Pelvic Bone Marrow Hounsfield Units to Predict Cytopenia During Anal Cancer Chemoradiation
30. Hematologic Toxicity During Anal Cancer Treatment: The Importance of Pelvic Bone Marrow Volume and Limiting Radiation Dose to a Critical Marrow Volume
31. Endorectal MRI in the Initial Assessment of Prostate Cancer: Radiographic Findings and Impact on Radiotherapeutic Treatment Decisions
32. Evaluation of Clinical Target Volume Delineation Before and After a Teaching Intervention: Creation of a Postoperative Prostate and Seminal Vesicle Fossae Contouring Module
33. Dose Response for Salvage Radiation Therapy After Radical Prostatectomy in Margin-Positive Prostate Cancer
34. Contemporary Update of a Multi-institutional Predictive Nomogram for Salvage Radiation Therapy After Prostatectomy
35. Late Toxicity After Post Prostatectomy Radiation Therapy: Evaluating RTOG 0534 Tissue-Sparing Guidelines
36. Defining Long Term Failure Risk in Patients With an Undetectable PSA After Salvage Radiation
37. Long-Term Outcome of Prostate Cancer Patients Who Fail Salvage Radiation Therapy and Radical Prostatectomy
38. Late Gastrointestinal and Genitourinary Toxicity and Quality of Life After Treatment for Localized Prostate Cancer: Redefining Optimal Rectal DVH Parameters for Intensity Modulated Radiation Therapy
39. Salvage Radiation Therapy After Postprostatectomy Failure: Benefits of Hormonal Therapy and Pelvic Nodal Radiation Are Not Necessarily Limited to “High-Risk” Cases
40. Refining Intermediate Risk Prostate Cancer: An Analysis of Prostate Biopsy Pathology and Implications for Hormone Therapy With Dose Escalated Radiation
41. PSA Halving Time of ≤2 Weeks and Post-RT PSA Nadir < 0.1 ng/mL are Associated With Excellent Biochemical Control for High-Risk Prostate Cancer: Implications Regarding the Need for Long-term ADT With Dose Escalated RT
42. Anwendung der dynamischen Simulation zur Sicherheitsanalyse industrieller Kolonnen
43. Do Diabetic Patients Experience More Toxicity After External Beam Radiation Therapy For Prostate Cancer?
44. Outcomes of definitive chemoradiation for squamous cell carcinoma of the anus and the effect of radiation technique on hematologic parameters.
45. Combined Modality Therapy for Rectal Cancer: Analysis of Potential Differences in Disease Presentation, Treatment Adherence, and Treatment Outcome According to Race
46. Post-treatment CEA Values, and CEA Trends at the Time of Uncertain Post-treatment Imaging, Have Prognostic Value after Combined Modality Therapy for Rectal Cancer
47. Impact of MR on CT-based Treatment Planning and Acute Toxicity for Prostate Cancer Patients Treated with Intensity-modulated Radiotherapy (IMRT)
48. Can SBRT of 45 Gy in 3 Fractions be Safely Delivered to Unresectable Pancreas Cancer Patients
49. Dose Escalated Radiation Therapy for High Risk Prostate Cancer: Outcomes in the Modern Era with Short Term Androgen Deprivation Therapy
50. Image Guided Radiotherapy after Radical Prostatectomy: A Report of Total Setup Error using Surgical Clips as Fiducials
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.